Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 10,456,392
🏛 Food and Drug Administration (FDA)FDA-2026-E-8230
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jul 30, 2026No comment period